ORCHARD THERAPEUTICS PLC Accounts Receivable
ORCHARD THERAPEUTICS PLC had Accounts Receivable of $6.19 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-11-13
- 2023-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $6.19M.
- 2023-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $9.55M.
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $8.47M.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $4.23M.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-09-30 | $6.19M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $9.55M 10-Q · filed 2023-08-10 |
| 2022-12-31 | $8.47M 10-Q · filed 2023-11-13 |
| 2022-09-30 | $4.23M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $4.13M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.11M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.48M 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.07M 10-Q · filed 2021-11-04 |
| 2020-12-31 | $878.00K 10-K · filed 2022-03-30 |
| 2020-09-30 | $3.18M 10-Q · filed 2020-11-03 |
| 2020-06-30 | $723.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $709.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.44M 10-K · filed 2021-03-02 |
| 2018-12-31 | $2.10M 10-K · filed 2020-02-27 |